{"id":"W2005981818","doi":"10.1016/j.clml.2013.12.015","title":"Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma","year":2014,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Deutsche Forschungsgemeinschaft; National Cancer Institute; Celgene; Amgen; American Society of Hematology","keywords":"Thalidomide; Medicine; Lenalidomide; Multiple myeloma; Pomalidomide; Oncology; Teniposide; Clinical trial; Bortezomib; Internal medicine; Cyclophosphamide; Melphalan; Pharmacology; Prednisone; Chemotherapy; Etoposide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.02413193,0.001498745,0.01744023,0.001176553,0.0001701246,0.00007135824,0.0007688385,0.002777884,0.0001594991],"category_scores_gemma":[0.04829747,0.001154769,0.003862093,0.001153307,0.00145018,0.0002162694,0.001004351,0.002044062,0.0001616751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002329053,"about_ca_system_score_gemma":0.004492335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004595842,"about_ca_topic_score_gemma":0.0002144758,"domain_scores_codex":[0.972306,0.01108135,0.01124158,0.002567482,0.001259735,0.001543903],"domain_scores_gemma":[0.9591464,0.03301345,0.003679907,0.002162664,0.0002575263,0.001740042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003939034,0.006765353,0.01209079,0.008164853,0.0009601191,0.0008614726,0.00006709585,2.024166e-7,0.00001455147,0.00002192833,0.0004366455,0.966678],"study_design_scores_gemma":[0.08686087,0.007707328,0.2681273,0.03152999,0.002594309,0.0002668931,0.00004221057,0.001077296,0.00006507785,0.00009316303,0.6001364,0.001499216],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4786736,0.5143601,0.00002076547,0.0001165781,0.0007524979,0.005117292,0.0002641009,0.00009060418,0.000604446],"genre_scores_gemma":[0.1839097,0.8127165,0.0007485801,0.0001224025,0.0009966774,0.0004326899,0.0004277682,0.0002023472,0.0004433708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9651787,"threshold_uncertainty_score":0.9997762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2745757903204223,"score_gpt":0.5036168554340602,"score_spread":0.2290410651136379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}